Clinical Trial Update: A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the addition of Vitamin D to standard treatment in new pulmonary tuberculosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Peter Daley | Conditions: Pulmonary Tuberculosis | Phase 3 | Status: COMPLETED